Sana Biotechnology SANA
NASDAQ SANA
$2.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Cash from Financing Activities (2020 - 2026)

Updated

Sana Biotechnology (SANA) recorded Cash from Financing Activities of $93.58 million in Q2 2026, compared with $561,000 a year earlier.

Analysis

Sana Biotechnology (SANA) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, Sana Biotechnology's Cash from Financing Activities came in at $220.64 million as of Jun 30, 2026; for FY2025, it came in at $128.73 million, down 35.6% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -21.6% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $199.75 million in FY2024 (+531.2%), $31.65 million in FY2023 (+544.1%), $4.91 million in FY2022 (-99.2%) and $631.75 million in FY2021 (+45.0%).
  • Quarterly Cash from Financing Activities has ranged from -$128,000 in Q1 2026 to $186.4 million in Q1 2024 over the past five years.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 374.2% in Q2 2022, against a decline of 99.9% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$128,000 (Q1 2026), $17.65 million (Q4 2025) and $109.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -5.05 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -47.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 2.34 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -3.66 Bn
10 Sana Biotechnology 864.99 Mn 864.99 Mn - 93.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.58 Mn
Mar 31, 2026 -128,000.00
Dec 31, 2025 17.65 Mn
Sep 30, 2025 109.54 Mn
Jun 30, 2025 561,000.00
Mar 31, 2025 982,000.00
Dec 31, 2024 643,000.00
Sep 30, 2024 2.08 Mn
Jun 30, 2024 10.63 Mn
Mar 31, 2024 186.40 Mn
Dec 31, 2023 1.72 Mn
Sep 30, 2023 187,000.00
Jun 30, 2023 29.51 Mn
Mar 31, 2023 236,000.00
Dec 31, 2022 1.06 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 1.58 Mn
Mar 31, 2022 652,000.00
Dec 31, 2021 3.12 Mn
Sep 30, 2021 1.60 Mn
API Access

Sana Biotechnology Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SANA&period=max&api_key=YOUR_API_KEY